Intensity modulated radiation therapy with simultaneous integrated boost based dose escalation on neoadjuvant chemoradiation therapy for locally advanced distal esophageal adenocarcinoma

doi:10.4251/wjgo.v8.i5.474

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5584)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

424

WORD

274

HTML

2409

Figures (1-2)

160

Tables (1-4)

126

Sum=3393

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

837

Download

1354

Sum=2191

May 15, 2016 (publication date) through May 19, 2024

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Oncol. May 15, 2016; 8(5): 474-480
Published online May 15, 2016. doi: 10.4251/wjgo.v8.i5.474

Table 3 Postoperative toxicity after neoadjuvant treatment followed by surgery

Pulmonary	5
Pneumonia	3
Pneumonitis	2
Cardiac¹	1
Surgery related	6
Anastomotic leakage	4
Anastomotic stricture	1
Wound infection	1
Death within admission	0

¹Cardiac toxicities include heart attack, cardiac rhythm changes, pericardia effusion.

Citation: Zeng M, Aguila FN, Patel T, Knapp M, Zhu XQ, Chen XL, Price PD. Intensity modulated radiation therapy with simultaneous integrated boost based dose escalation on neoadjuvant chemoradiation therapy for locally advanced distal esophageal adenocarcinoma. World J Gastrointest Oncol 2016; 8(5): 474-480
URL: https://www.wjgnet.com/1948-5204/full/v8/i5/474.htm
DOI: https://dx.doi.org/10.4251/wjgo.v8.i5.474